What is NDC 0362-1096?

0362-1096 is the product NDC for Lignospan Forte, Lidocaine hydrochloride 20 mg/mL; Epinephrine bitartrate .02 mg/mL injection, solution, listed with the FDA by Septodont, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Lignospan Forte (Lidocaine Hydrochloride and Epinephrine).

What is the active ingredient?

Lidocaine hydrochloride, Epinephrine bitartrate.

Septodont, Inc., NDC labeler code 0362. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lignospan Forte?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lignospan Forte NDC 0362-1096 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0362-1096Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00362-1096Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0362-1096-70	0036210967000362109670	5 BLISTER PACK in 1 CARTON (0362-1096-70) / 10 CARTRIDGE in 1 BLISTER PACK / 1.7 mL in 1 CARTRIDGEMarketed from Dec 1, 2017

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lignospan Forte
Generic name (nonproprietary): lidocaine hydrochloride and epinephrine
Active ingredients: Lidocaine hydrochloride — 20 mg/mLEpinephrine bitartrate — .02 mg/mL
Dosage form: Injection, Solution
Route: Submucosal
Labeler: Septodont, Inc.NDC labeler code 0362
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 088389
Marketing start: Dec 1, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Agonists (Mechanism)Amides (Chemical structure)Catecholamines (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 0362-1096_cb2397ba-49a9-4c95-bbde-17d1260607eeSPL ID cb2397ba-49a9-4c95-bbde-17d1260607eeSPL set ID f8ca7d03-01c8-450f-9279-59789c3497eaRxCUI 1011814, 1657026UNII V13007Z41A, 30Q7KI53AK
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400362109670 followed by a unit qualifier and the quantity

Package 00362-1096-70. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 20, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE LIGNOSPAN Solutions are indicated for the production of local anesthesia for dental procedures by nerve block or infiltration techniques. Only accepted procedures for these techniques as described in standard textbooks are recommended.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0362-1096

What is NDC 0362-1096?: 0362-1096 is the product NDC for Lignospan Forte, Lidocaine hydrochloride 20 mg/mL; Epinephrine bitartrate .02 mg/mL injection, solution, listed with the FDA by Septodont, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lignospan Forte (Lidocaine Hydrochloride and Epinephrine).
What is the active ingredient?: Lidocaine hydrochloride, Epinephrine bitartrate.
Who is the labeler?: Septodont, Inc., NDC labeler code 0362. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lignospan Forte?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 088389

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 088389
Product	Strength	Form · route	Labeler	Product NDC
Lidocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride 20 mg/mL; Epinephrine bitartrate .02 mg/mL	Injection, SolutionSubmucosal	Septodont, Inc.	0362-0262
Lidocainelidocaine hydrochloride and epinephrine bitartrate	Lidocaine hydrochloride 20 mg/mL; Epinephrine bitartrate .02 mg/mL	Injection, SolutionSubmucosal	Henry Schein Inc.	0404-6500
Lidocainelidocaine hydrochloride and epinephrine bitartrate	Lidocaine hydrochloride 20 mg/mL; Epinephrine bitartrate .02 mg/mL	Injection, SolutionSubmucosal	Patterson Dental	50227-1020
Lidocainelidocaine hydrochloride and epinephrine bitartrate	Lidocaine hydrochloride 20 mg/mL; Epinephrine bitartrate .02 mg/mL	Injection, SolutionSubmucosal	Darby Dental Supply, LLC	66467-9710
Lidocainelidocaine hydrochloride and epinephrine bitartrate	Lidocaine hydrochloride 20 mg/mL; Epinephrine bitartrate .02 mg/mL	Injection, SolutionSubmucosal	Benco Dental	66975-415
Xylocainelidocaine hydrochloride and epinephrine bitartrate	Lidocaine hydrochloride 20 mg/mL; Epinephrine bitartrate 20 ug/mL	Injection, SolutionSubmucosal	Dentsply Pharmaceutical	66312-181

Lignospan Forte (Lidocaine hydrochloride and epinephrine) NDC 0362-1096